ISRAEL AT WAR - DAY 61

search

BioNTech to build factory in Jerusalem to develop and produce vaccines

A technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company's facility in Puurs, Belgium in March 2021. (Pfizer via AP)
A technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company's facility in Puurs, Belgium in March 2021. (Pfizer via AP)

BioNTech, the German biotech company that formulated the COVID vaccine sold by Pfizer, signs a memorandum of understanding to build a new facility in Jerusalem to develop and produce vaccines.

The center, to be located in the Har Hotzvim area of the capital, will focus on mRNA technologies for medications and vaccinations to fight cancer and possible future pandemics. The agreement also gives Israel the ability to be the first to purchase vaccines in the case of a pandemic outbreak.

A representative of BioNTech signs the memorandum in the capital with Jerusalem Mayor Moshe Lion, as well as Health and Finance ministry officials.

Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.